Groningen

• Study of Targeted Therapies for the Treatment of Adult Participants with Moderate to Severe Crohn’s Disease Recruiting
  2024-513009-30-00 4 2024-11-21 Moderate to Severe Crohn’s Disease
• HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t … Recruiting
  2024-514917-36-00 5 2024-11-21 Patients with High Risk Neuroblastoma
• The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlle … Recruiting
  2024-514055-15-00 6 2024-11-19 Pulmonary sarcoidosis
• Macrophage imaging GCA Recruiting
  2024-514491-40-00 4 2024-11-12 giant cell arteritis
• Subtyping Primary Aldosteronism with Para-chloro-2-[18F]fluoroethyl-etomidate ([18F]CETO) Recruiting
  2023-508254-26-00 7 2024-11-06 Primary aldosteronism
• A rollover study of avapritinib (also called BLU-285) in adults Who Participated in a Previous Avapritinib Study Recruiting
  2024-514969-18-00 6 2024-11-05 Systemic Mastocytosis
• GSDIa Disease Monitoring Program Recruiting
  2023-510219-20-00 11 2024-11-04 Glycogen storage disease type Ia (GSDIa)
• RESTART; Autologous Transplantation of Adult Salivary Gland Stem Cells to Restore Submandibular Gland Function after Radiotherapy Recruiting
  2024-512968-57-00 1 2024-11-01 Patients operated with curative intend for head and neck cancer with a
• A phase 3 trial comparing a therapeutic cancer vaccine OSE2101 to chemotherapy docetaxel in patients with metastatic Non-Small Cell Lung Can … Recruiting
  2023-509340-10-00 5 2024-10-29 Patients with HLA-A2 positive phenotype and metastatic Non-Small Cell
• Small patient study to explore the anticancer effect of cannabis oil in untreatable patients with liver cancer Recruiting
  2024-514049-13-02 4 2024-10-29 Patients with untreatable hepatocellulare carcinoma
• Timing of start of systemlc treatment for asymptomatic MEtastasized PANcreatic cancer (TIMEPAN): a prospective multicenter patient preferenc … Recruiting
  2023-509465-20-00 5 2024-10-28 metastatic pancreatic cancer
• Local Levobupivacaine for pain reflief after esophageal ESD Recruiting
  2024-510912-66-00 6 2024-10-22 Visible esophageal lesions ((pre)cancerous)
• PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy: a Randomized … Recruiting
  2023-504144-33-01 11 2024-10-17 esophageal cancer
• Can we Save the rectum by watchful waiting or transanal surgery following short- or long-course radioTherapy and Additional local oR systemi … Recruiting
  2024-514620-17-00 4 2024-10-14 Patients with early-stage rectal cancer (defined as early rectal cance
• TAP-TAU Recruiting
  2023-505430-10-00 10 2024-10-10 Mild cognitive impairment and dementia
• Clinical trial comparing MK-2870 given with pembrolizumab to pembrolizumab alone in participants who have had surgery for NSCLC Recruiting
  2023-508012-35-00 5 2024-10-02 Newly diagnosed NSCLC with resectable clinical Stage II, IIIA or IIIB
• Tranexamic acid to prevent OpeRation in Chronic subdural Hematoma (TORCH) Recruiting
  2024-514927-40-02 11 2024-10-01 Chronic Subdural Hematoma
• A lower dose olaparib, combined with a drug which inhibits olaparib degradation, to increase tolerability and decrease the price of the trea … Recruiting
  2024-516414-38-00 11 2024-10-01 Cancer
• GREAT; GRoningen Early-PD Ambroxol Treatment Trial Recruiting
  2024-514976-41-00 4 2024-09-23 Parkinson's disease
• FREE-study Recruiting
  2024-516277-68-00 6 2024-09-19 Crohn's disease Ulcerative colitis
• Dose tapering and Early Discontinuation to InCreAse cosT-effictIveness Of immunotherapy for Non-small cell lung carcinoma trial number 1 (NV … Recruiting
  2024-516195-15-00 5 2024-09-10 Advanced NSCLC
• A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s dise … Recruiting
  2024-511110-21-00 1 2024-09-09 Parkinson’s Disease
• A Phase I/II Study of AZD5863 in Adult Participants with Advanced or Metastatic Solid Tumors Recruiting
  2023-504139-42-00 7 2024-09-06 Advanced or metastatic solid tumors
• Treatment with leflunomide in patients with polymyalgia rheumatica Recruiting
  2024-514210-12-00 5 2024-09-01 polymyalgia rheumatica

Showing 217–240 of 679 trials